Compounds possessing neurotrophic properties may represent a possible treatment for neurodegenerative disorders such as amyotrophic lateral sclerosis. Xaliproden (SR57746A), an orally-active non-peptide compound, which has been found to exhibit neurotrophic effects in vitro and in vivo, increase the lifespan and delay the progression of motor neuron degeneration in PMN mice. We have used a quantitative reverse transcription/polymerase chain reaction amplification technique to study the regulation of neurotrophin mRNA and trk mRNA expression in PMN mice. NGF and NT-3 mRNA are downregulated in PMN mice. These deficiencies can be overcome by treatment with xaliproden. Such an effect could contribute to neurotrophic effects of xaliproden in vivo and in vitro.
SagotY., VejsadaR., and KatoA.C.. 1997. Clinical and molecular aspects of motoneuron diseases: animal models, neurotrophic factors and Bcl-2 oncoprotein.Trends Pharmacol.18: 330.
2.
JohnsonD., LanahanA., BuckC.R., SehgalA., MorganC., MercerE., BothwellM., and ChaoM.V.1986. Expression and structure of the human NGF receptor.Cell47: 545.
3.
BattlemanD.S., GellerA.I., and ChaoM.V.. 1993. HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75 hNGFR defines high-affinity NGF binding.J. Neurosci.13: 941.
4.
ChaoM.V.. 1992. Neurotrophin receptors: a window into neuronal differentiation.Neuron9: 583.
5.
HempsteadB.L., PatilN., TheilB., and ChaoM.V.. 1990. Deletion of cytoplasmic sequences of the NGF receptor leads to loss of high affinity ligand binding.J. Biol. Chem.265: 9595.
6.
HempsteadB.L., Martin-ZancaD., KaplanD.R., ParadaL.F., and ChaoM.V.. 1991. High affinity NGF binding requires coexpression on the trk proto-oncogene and the low affinity NGF receptor.Nature350: 678.
7.
MeakinS.O., and ShooterE.M.. 1991. Molecular investigations on the high affinity nerve growth factor receptor.Neuron6: 153.
8.
Cordon-CardoC., TapleyP., JingS., NanduriV., O'RourkeE., LamballeF.1991. The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3.Cell66: 173.
9.
GlassD.J., NyeS.H., HantzopoulosP., MacchiM.J.1991. TrkB mediates BDNF/NT-3 dependant survival and proliferation in fibroblasts lacking the low affinity NGF receptor.Cell66: 405.
10.
HempsteadB.L., RabinS.J., KaplanL.1992. Over-expression of the trk tyrosine kinase rapidly accelerates nerve growth factor-induced differentiation.Neuron9: 883.
11.
KaplanD.R., Martin-ZancaD., and ParadaL.F.. 1991. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF.Nature350: 158.
12.
KleinR., JingS., NanduriV., O'RourkeE., and BarbacidM.. 1991. The trk proto-oncogen encodes a receptor for nerve growth factor.Cell65: 189.
13.
KleinR., NanduriV., JingS.1991. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3.Cell66: 395.
14.
LamballeF., SmeyneR.J., and BarbacidM.. 1994. Developmental expression of trkC, the neurotrophin-3 receptor, in the mammalian nervous system.J. Neurosci.14: 14.
15.
LindsayR.M., WiegandS.J., AnthonyC.A., and DistefanoP.S.. 1994. Neurotrophic factors: from molecule to man.Trends Neurosci.6: 182.
16.
SoppetD., EscandonE., MaragosJ.1992. The neurotrophic factors brain derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor.Cell65: 895.
17.
SquintoS.P., StittT.N., AldrichT.H.1991. TrkB encodes a functional receptor for brain derived neurotrophic factor and neurotrophin-3 but not nerve growth factor.Cell65: 885.
18.
IpN.Y., StittT.N., TapleyR.1993. Similarities and differences in the way neurotrophins interact with the trk receptors in neuronal and nonneuronal cells.Neuron10: 137.
19.
FournierJ., KeaneP.E., FerraraP., and SoubrieP.. 1997. SR57746A: an orally active non-peptide compound with neuroprotective effects.CNS Drug Reviews3: 148.
20.
DuongF., FournierJ., KeaneP.E.1998. The effect of the non-peptide compound SR57746A on the progression of the disease state of the PMN mouse.Br. J. Pharmacol.124: 811.
21.
SchmalbruchH., JensenH.J.S., BjaergM., KamienieckaZ., and KurlandL. A.. 1991. New mouse mutant with progressive motor neuronopathy.J. Neuropathol. Exp. Neurol.50: 192.
22.
KennelP.F., FonteneauP., MartinE.1996. Electromyographical and motor performance studies in the PMN mouse model of neurodegenerative disease.Neurobiol. Dis.3: 137.
23.
DuongH.T.F., KeaneP.E., WarterJ.M., PoindronP., and PassillyP.. 1999. Effect of the non-peptide neurotrophic compound SR57746A on the phenotypic survival of mouse purified motoneuron.Br. J. Pharmacol.128: 1385.
24.
BrunialtiA.L., PoirierC., SchmalbruchH., and GuenetJ.L.. 1995. The mouse mutation progressive motor neuronopathy (PMN) maps.to chromosome 13.Genomics29: 131.
25.
FournierJ., SteinbergR., GauthierT.1993. Protective effects of SR57746A in central and peripheral models of neurodegenerative disorders in rodents and primates.Neuroscience55: 629.
26.
LabieC., LafonC., FournierJ.1998. Effect of the non-peptide neuroprotective compound SR57746A on NGF and BDNF synthesis in primary astrocytes in culture.Br. J. Pharmacol.123: 80P.
27.
GriesbeckO., ParsadanianA., SendtnerM., and ThoenenH.. 1995. Expression of neurtrophins in skeletal muscle: quantitative comparison and significance for motoneuron survival and maintenance of function.J. Neurosci. Res.42: 21.
28.
WeisC., MarksteinerJ., and HumpelC.. 2001. Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert.Neuroscience102: 129.
29.
SagotY., RosseT., VejsadaR., PerreletD., and KatoA.C.. 1998. Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease.J. Neurosci.18: 1132.
30.
HaaseG., KennelP., PettmanB.1997. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors.Nat. Med.3: 429.
31.
TerenghiG.. 1999. Peripheral nerve regeneration and neurotrophic factors.J Anat.194: 1.
32.
SendtnerM., HoltmannB., and HughesR.A.. 1996. The response of motoneurons to neurotrophins.Neurochem. Res.21: 831.
33.
MartinN., JaubertJ., GounonP.2002. A missense mutation in Tbce causes progressive motor neuronopathy in mice.Nature Genetics32: 443.
34.
FernyhoughP., and IshiiD.N.. 1987. Nerve growth factor modulates tubulin transcript levels in pheochromocytoma PC12 cells.Neurochem. Res.12: 891.
